003550:KRXLG Corp Analysis
Data as of 2026-03-11 - not real-time
₩93,300.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
LG Corp. is trading at KRW 93,300, comfortably above its 20‑day SMA (KRW 96,525) but below the 50‑day SMA (KRW 90,328), indicating a short‑term pull‑back within a broader bullish backdrop (trend_direction: bullish). The MACD histogram is negative and the MACD signal is bearish, while the RSI sits near the midpoint at 48.5, suggesting limited upside momentum in the near term. Valuation metrics are mixed: a forward P/E of 8.64 is far below the industry average of 36.97, pointing to a relative value advantage, yet the DCF‑derived fair value (KRW 74,563) sits well under the current price, hinting at possible overvaluation on cash‑flow grounds. Dividend yield of 3.29% coupled with an 89% payout ratio provides attractive income but raises questions about sustainability given modest ROE (3.2%).
Fundamentally, the company delivers solid cash generation (operating cash flow KRW 1.05 trillion, free cash flow KRW 0.61 trillion) and maintains a strong net‑cash position despite a debt‑to‑equity of 2.29. Revenue growth is modest at 2.7% and margins are thin (gross margin 20.1%, operating margin 21%). Low beta (0.40) and a volatility of 61% over 30 days suggest price swings but limited systematic risk. The combination of a bullish longer‑term trend, undervalued relative P/E, and a robust dividend makes the stock a candidate for medium‑term buying, while short‑term caution is advised due to bearish MACD and proximity to resistance at KRW 107,800.
Fundamentally, the company delivers solid cash generation (operating cash flow KRW 1.05 trillion, free cash flow KRW 0.61 trillion) and maintains a strong net‑cash position despite a debt‑to‑equity of 2.29. Revenue growth is modest at 2.7% and margins are thin (gross margin 20.1%, operating margin 21%). Low beta (0.40) and a volatility of 61% over 30 days suggest price swings but limited systematic risk. The combination of a bullish longer‑term trend, undervalued relative P/E, and a robust dividend makes the stock a candidate for medium‑term buying, while short‑term caution is advised due to bearish MACD and proximity to resistance at KRW 107,800.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and signal
- RSI near neutral territory
- Price approaching resistance zone
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Bullish overall trend and increasing volume
- Forward P/E far below industry average
- Attractive dividend yield despite payout concerns
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Strong cash flow generation and net‑cash position
- Modest revenue growth and low ROE
- Low beta indicating limited market‑wide volatility
Key Metrics & Analysis
Financial Health
Revenue Growth2.70%
Profit Margin9.43%
P/E Ratio8.6
ROE3.22%
ROA2.17%
Debt/Equity2.29
Op. Cash Flow₩1054.6B
Free Cash Flow₩610.0B
Industry P/E37.0
Technical Analysis
TrendBullish
RSI48.5
Support₩87,000.00
Resistance₩107,800.00
MA 20₩96,525.00
MA 50₩90,328.00
MA 200₩80,779.50
MACDBearish
VolumeIncreasing
Fear & Greed Index76.88
Valuation
Fair Value₩74,562.79
Target Price₩102,833.34
Upside/Downside10.22%
GradeUndervalued
TypeValue
Dividend Yield3.29%
Risk Assessment
Beta0.40
Volatility61.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.